化合物SM-6586 T16897
面议
- TargetMol
- 生产商
- 进口
- 美国
- 现货
- 全国
- 2
- 0
Product IntroductionBioactivity英文名: SM-6586描述: SM-6586 是一种有效的钙离子通道拮抗剂，对 Na+/H+ 和 Na+/Ca2+ 交换通道有抑制作用，可用于研究脑血管疾病和高血压等疾病。体内活
AI问答
配套的仪器设备？
可以搭配的相关耗材试剂？
耗材描述
Product Introduction
Bioactivity
英文名: SM-6586
描述: SM-6586 是一种有效的钙离子通道拮抗剂，对 Na+/H+ 和 Na+/Ca2+ 交换通道有抑制作用，可用于研究脑血管疾病和高血压等疾病。
体内活性: In spontaneously hypertensive rats treated with SM-6586, the survival rate after bilateral common carotid artery ligation is higher, the brain water content is lower, and the ATP level is higher, while lactate level is decreased. In focal ischemia models, the SM-treated group shows a reduction of T1 relaxation time. Additionally, the brain water content is significantly decreased in the SM-treated group[1].
存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: SM6586 | SM-6586 | SM 6586
相关产品: SN 6 | Terfenadine | CGP37157 | SEA0400 | KB-R7943 mesylate | Benzamil | FR183998 free base | PPADS tetrasodium
相关库: Membrane Protein-targeted Compound Library
Bioactivity
英文名: SM-6586
描述: SM-6586 是一种有效的钙离子通道拮抗剂，对 Na+/H+ 和 Na+/Ca2+ 交换通道有抑制作用，可用于研究脑血管疾病和高血压等疾病。
体内活性: In spontaneously hypertensive rats treated with SM-6586, the survival rate after bilateral common carotid artery ligation is higher, the brain water content is lower, and the ATP level is higher, while lactate level is decreased. In focal ischemia models, the SM-treated group shows a reduction of T1 relaxation time. Additionally, the brain water content is significantly decreased in the SM-treated group[1].
存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: SM6586 | SM-6586 | SM 6586
相关产品: SN 6 | Terfenadine | CGP37157 | SEA0400 | KB-R7943 mesylate | Benzamil | FR183998 free base | PPADS tetrasodium
相关库: Membrane Protein-targeted Compound Library
猜你喜欢
感兴趣产品